These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26035801)

  • 1. The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.
    Grosse SD; Palomaki GE; Mvundura M; Hampel H
    Genet Med; 2015 Jun; 17(6):510-1. PubMed ID: 26035801
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of genetic screening for Lynch syndrome in Germany.
    Severin F; Stollenwerk B; Holinski-Feder E; Meyer E; Heinemann V; Giessen-Jung C; Rogowski W
    Genet Med; 2015 Oct; 17(10):765-73. PubMed ID: 25569434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal privacy: Quantifying life years lost if the right to informational self-determination guides genetic screening for Lynch syndrome.
    Gansen F; Severin F; Schleidgen S; Marckmann G; Rogowski W
    Health Policy; 2019 Oct; 123(10):1004-1010. PubMed ID: 31492458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.
    Mvundura M; Grosse SD; Hampel H; Palomaki GE
    Genet Med; 2010 Feb; 12(2):93-104. PubMed ID: 20084010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family matters in lynch syndrome.
    Kastrinos F; Steyerberg EW
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.
    Leenen CH; Goverde A; de Bekker-Grob EW; Wagner A; van Lier MG; Spaander MC; Bruno MJ; Tops CM; van den Ouweland AM; Dubbink HJ; Kuipers EJ; Dinjens WN; van Leerdam ME; Steyerberg EW
    Genet Med; 2016 Oct; 18(10):966-73. PubMed ID: 26938782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
    West NP
    Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
    [No Abstract]   [Full Text] [Related]  

  • 11. Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.
    Resnick K; Straughn JM; Backes F; Hampel H; Matthews KS; Cohn DE
    Obstet Gynecol; 2009 Sep; 114(3):530-536. PubMed ID: 19701031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
    Chen YE; Kao SS; Chung RH
    PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
    Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
    Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families.
    Ghorbanoghli Z; Jabari C; Sweidan W; Hammoudeh W; Cortas G; Sharara AI; Abedrabbo A; Hourani I; Mahjoubi B; Majidzadeh K; Tözün N; Ziada-Bouchaar H; Hamoudi W; Diab O; Khorshid HRK; Lynch H; Vasen H
    Fam Cancer; 2018 Apr; 17(2):209-212. PubMed ID: 28685475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying persons with Lynch syndrome: why and how?
    Ladabaum U
    Dig Dis Sci; 2014 Dec; 59(12):2841-4. PubMed ID: 25344908
    [No Abstract]   [Full Text] [Related]  

  • 16. Lynch Syndrome Testing: A Missed Opportunity in the Era of Precision Medicine.
    Pasche B; Pennison MJ; DeYoung B
    JAMA; 2016 Jul; 316(1):38-9. PubMed ID: 27380341
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for Lynch syndrome: it is time to shift the focus.
    Kidambi TD; Terdiman JP
    Dig Dis Sci; 2015 Feb; 60(2):586-7. PubMed ID: 25563721
    [No Abstract]   [Full Text] [Related]  

  • 18. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Hall MJ
    J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should have genetic testing for the Lynch syndrome?
    Burt RW
    Ann Intern Med; 2011 Jul; 155(2):127-8. PubMed ID: 21768586
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
    Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ
    PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.